4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-26-006263
Options or other derivatives
- CEO bought 34,940 shares at $2.86 ($99,998)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Pershing Edward CEO | 2026-02-09 | Purchase · Series D-1 Convertible Preferred Stock | +34,940 | $2.86 | $99,998 | 2,613,807 | D |
Loading xslF345X05/ownership.xml…